Introduction
Over the past several years, remarkable progress has been made in understanding the biological substrates of motor neurone disease (MND) (Kuncl et al 1992 , Smith 1992 , Williams & Windebank 1993 . Genetic factors in the aetiology of MND have been identified, animal models have been developed and characterized, hypothetical pathogenetic mechanisms have been proposed and are being tested and promising therapeutic approaches are being explored. The investigation of MND is now one of the most exciting and challenging areas of research and provides a superb illustration of the dynamic interactions between clinical and basic research in neuroscience.
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Human motor neurone disease

Clinical syndromes
Human MND, including amyotrophic lateral sclerosis (ALS), are characterized by paralysis and a variety of other motor signs. The distinct clinical syndromes (i.e. inherited upper vs lower motor neurone signs) are the result of selective degeneration of subsets of motor nerve cells (Kuncl et al. 1992 , Price et al. 1992b , Harding 1993 , Williams & Windebank 1993 .Weakness/muscle atrophy is attributed to large α-motor neurones of the brainstem and spinal cord, whereas spasticity, hyperreflexia, and extensor plantar signs result from lesions of upper motor neurones (Brownell et al. 1970 , Delisle & Carpenter 1984 ,Tandan & Bradley 1985 , Banker 1986 , Hirano, 1991 , Kuncl et al. 1992 , Oppenheimer & Esiri 1992 , Price et al. 1992a , b, Harding 1993 , Williams & Windebank 1993 . With a world-wide prevalence of >4-6/100 000, classical ALS is characterized by the presence of all of these signs, and electrodiagnostic studies disclose fibrillations, fasciculations, and giant polyphasic potentials; muscle biopsies demonstrate denervation atrophy. The spinal muscular atrophies (SMA) of infancy and childhood, the second most common form of autosomal recessive disease (1:6000 new births) (Harding 1993 , Williams & Windebank 1993 , Melki et al. 1994 , are classified on the basis of severity into type I (Werdnig-Hoffman disease), type II, or type III (Kugelberg-Welander disease). Kennedy's disease, an adult-onset X-linked recessive bulbo-SMA (Fischbeck et al. 1991 , Kuncl et al. 1992 , Matsuura et al. 1992 , occurs in males and is characterized by progressive limb weakness and difficulty in swallowing.
Aetiological factors
Age is a risk factor in the expression of these diseases.Classical ALS usually begins in late life (Williams & Windebank 1993) , whereas SMA occurs in infancy and childhood (Hamida & Hentati 1991 , Hausmanowa-Petrusewicz 1991 , Harding 1993 . Approximately 10% of cases of adult-onset ALS are familial and show autosomal dominant inheritance associated with age-dependent penetrance (Siddique et al. 1989 (Siddique et al. ,1991 In families with early-onset familialALS (FALS). missense mutations have been discovered in superoxide dismutase 1 (SOD1) (Deng et al. 1993 , Rosen et al. 1993 , which is encoded by an ~15-kD gene comprised of five exons on chromosome 21 (Rosen et al. 1993 (Imlay & Linn 1988 , Halliwell 1992 , Stadtman 1992 . The majority of cases of childhood/juvenile SMA shows linkage to DNA markers on chromosome 5q13 (Melki et al. 1990) , and recent studies have demonstrated inherited and de novo deletions in these patients with SMA (Melki et al. 1994 ). Kennedy's disease is caused by an expansion of a tandem CAG trinucleotide repeat in exon 1 of the androgen receptor gene (X q11-12) (La Spada et al. 1991 , Caskey et al. 1992 , Doyu et al. 1992 , differences in repeat length correlate with the onset of disease.
Neuropathology
Various MND selectively involve subsets of motor nerve cells. Affected neurones frequently show accumulations of 10-nm neurofilaments (NF) in axons and cell bodies and a
